LGM Pharma   Report issue

For profit Phase 1 Phase 2
Founded: Boca Raton FL United States (2005)

Organization Overview

First Clinical Trial
None
First Marketed Drug
2005
acetylsalicylic acid (aspirin)
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

LGM PHARMA

Active Ingredients

Marketed Drugs (12)

Key: LGM Pharma (11) Acquired (1)

acetaminophen (tylenol) (2004)

acetylsalicylic acid (aspirin) (2001)

butalbital (fiornal) (2001)

caffeine (2001)

chenodeoxycholic acid (Chenix) (2009)

codeine (Phenergan) (2001)

glycopyrronium (robinul) (2012)

hydrocodone (hycodan) (2021)

mecamylamine (inversine) (2013)

nabumetone (relafen) (2019)

polyethylene glycol (2009)

ursodeoxycholic acid (2020)

Drugs in Phase 2 Trials (2)

Key: LGM Pharma (0) Acquired (2)

doxycycline (vibramycin) (1 trial)

s-equol (1 trial)

Drugs in Phase 1 Trials (2)

Key: LGM Pharma (0) Acquired (2)

codeine (Phenergan) (2 trials)

guaifenesin (2 trials)

Drugs in Other Trials (1)

Key: LGM Pharma (0) Acquired (1)

citrus flavonoid (1 trial)

Indications

Overview

  • Highest Phase: None
  • # of Trials: 4
  • # of Trial APIs: 5